Confluence Wealth Services Inc. Sells 523 Shares of The Clorox Company (NYSE:CLX)

Confluence Wealth Services Inc. reduced its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 28.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,298 shares of the company’s stock after selling 523 shares during the quarter. Confluence Wealth Services Inc.’s holdings in Clorox were worth $209,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of CLX. Brooklyn Investment Group lifted its holdings in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new stake in Clorox in the third quarter worth $27,000. Continuum Advisory LLC increased its position in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares during the last quarter. Carolina Wealth Advisors LLC purchased a new stake in Clorox in the third quarter worth $48,000. Finally, Friedenthal Financial purchased a new stake in Clorox in the third quarter worth $49,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

NYSE:CLX opened at $147.55 on Friday. The firm has a market capitalization of $18.26 billion, a price-to-earnings ratio of 51.41, a P/E/G ratio of 2.92 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The stock has a fifty day moving average of $161.83 and a 200 day moving average of $158.67. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same quarter last year, the business earned $2.16 earnings per share. On average, research analysts expect that The Clorox Company will post 6.86 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.31%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is currently 133.33%.

Analyst Ratings Changes

A number of research firms have issued reports on CLX. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. raised their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday. Evercore ISI raised their target price on Clorox from $145.00 to $155.00 in a research report on Tuesday. Barclays raised their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $158.21.

View Our Latest Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.